Kenji Tsukigawa
Kenji Tsukigawa publishes mostly in Molecular Biology, Biomaterials and Biomedical Engineering, on topics such as Nanoparticle-Based Drug Delivery, Protein Interaction Studies and Fluorescence Analysis and Nanoplatforms for cancer theranostics.
- World rank
- #4,016,590 of 7,710,434 ranked researchers
- Rank in Japan
- #107,716 of 383,136
- Works
- 47
- Citations
- 907
- Citations per work
- 19.3
What does Kenji Tsukigawa research?
Kenji Tsukigawa's work is mostly in Biochemistry, Genetics and Molecular Biology (21%), Materials Science (14%), Chemistry (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2145.1%
- Physical Sciences1327.1%
- Materials Science714.3%
- Chemistry36.4%
- Engineering36.4%
- Life Sciences1021.4%
- Health Sciences36.4%
- Medicine36.4%
- 1Molecular Biology21% of their works
- 2Biomaterials8% of their works
- 3Biomedical Engineering6% of their works
- 4Materials Chemistry6% of their works
- 5Organic Chemistry6% of their works
- 6Oncology6% of their works
Research topics
- Nanoparticle-Based Drug Delivery
- Protein Interaction Studies and Fluorescence Analysis
- Nanoplatforms for cancer theranostics
- Heme Oxygenase-1 and Carbon Monoxide
- Lanthanide and Transition Metal Complexes
- Photodynamic Therapy Research Studies
- Porphyrin and Phthalocyanine Chemistry
- Cancer Treatment and Pharmacology
Which keywords describe Kenji Tsukigawa's research?
The keywords of their largest research topics: Nanoparticles, Tumor Targeting, Drug Delivery, Nanocarriers, Photodynamic Therapy, Reactive Oxygen Species, Protein Binding and Serum Albumin.
- Taxanes
- Phthalocyanines
- Photosensitizers
- Lanthanide Luminescence
- Carbon Monoxide
- Photothermal Therapy
- Serum Albumin
- Reactive Oxygen Species
- Nanocarriers
- Tumor Targeting
- Nanoparticles
- Drug Delivery
- Photodynamic Therapy
- Protein Binding
- Fluorescence Imaging
- Cancer Treatment
- Heme Oxygenase-1
- MRI Contrast Agents
- Chemotherapy-Induced Peripheral Neuropathy
- Porphyrins
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Nanoparticles223 topics
- Tumor Targeting172 topics
- Drug Delivery111 topic
- Nanocarriers111 topic
- Photodynamic Therapy112 topics
- Reactive Oxygen Species112 topics
- Protein Binding101 topic
- Serum Albumin101 topic
- Fluorescence Imaging61 topic
- Photothermal Therapy61 topic
- Cancer Treatment51 topic
- Carbon Monoxide51 topic
- Heme Oxygenase-151 topic
- Lanthanide Luminescence51 topic
- MRI Contrast Agents51 topic
- Photosensitizers51 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Phthalocyanines41 topic
- Porphyrins41 topic
- Taxanes41 topic
Where does Kenji Tsukigawa work?
Kenji Tsukigawa's main affiliation in the publication record is Sojo University, Japan.
How many publications and citations does Kenji Tsukigawa have?
OpenAlex counts 47 works and 907 citations for Kenji Tsukigawa, an h-index of 12, ranking #4,016,590 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kenji Tsukigawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.